BIOMAT Database Logo BIOMAT Database Logo

Nasal potential difference: a clinical diagnostic test for cystic fibrosis. 1990

E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
Royal Brompton and National Heart Hospital, London, UK.

Patients with cystic fibrosis (CF) demonstrate a markedly more negative potential difference (PD) across respiratory epithelia than normal or "diseased" controls. A technique is described for the measurement of nasal PD in both children and adults. 145 non-CF subjects showed a mean PD of -19.0 mV (range -2 to -36) in comparison to 60 patients with cystic fibrosis with mean of -46.0 mV (range -32 to -77). Amongst the latter group those with more severe disease had a more negative PD. Measurement of nasal PD is easily learnt and rapidly performed and may provide an additional means of diagnosis for CF.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008839 Microelectrodes Electrodes with an extremely small tip, used in a voltage clamp or other apparatus to stimulate or record bioelectric potentials of single cells intracellularly or extracellularly. (Dorland, 28th ed) Electrodes, Miniaturized,Electrode, Miniaturized,Microelectrode,Miniaturized Electrode,Miniaturized Electrodes
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009297 Nasal Mucosa The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells. Nasal Epithelium,Schneiderian Membrane,Epithelium, Nasal,Membrane, Schneiderian,Mucosa, Nasal
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D005260 Female Females

Related Publications

E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
[Measurement of nasal transepithelial potential difference: a diagnostic test for cystic fibrosis].
January 1996, Revue de pneumologie clinique,
E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
[Nasal potential difference test to diagnose cystic fibrosis].
January 2006, Archivos de bronconeumologia,
E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
Employing the nasal potential difference as a diagnostic test for cystic fibrosis in neonates: potential pitfalls.
August 2002, The Journal of pediatrics,
E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
Nasal potential difference outcomes support diagnostic decisions in cystic fibrosis.
September 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
Nasal potential difference in cystic fibrosis patients presenting borderline sweat test.
May 1997, The European respiratory journal,
E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?
May 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
Chloride Conductance, Nasal Potential Difference and Cystic Fibrosis Pathophysiology.
February 2020, Lung,
E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
Reproducibility of nasal potential difference measurements in cystic fibrosis.
October 2007, Chest,
E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
Nasal potential difference measurements in patients with atypical cystic fibrosis.
June 2001, The European respiratory journal,
E W Alton, and D Currie, and R Logan-Sinclair, and J O Warner, and M E Hodson, and D M Geddes
Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF).
January 2013, Medycyna wieku rozwojowego,
Copied contents to your clipboard!